ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

If you need to track your glucose daily, you probably want a pain-free option. Besides pricking your finger, there are now wearable devices that are placed on your arm and connect to an app on your ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. | Walmart ...

Abstract: The insulin pump is a critical device for intensive insulin therapy in diabetic patients. Failures in insulin pump sets such as blockage and leakage can disrupt normal insulin delivery, ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...

Objective: To investigate the effect of short-term intensive insulin (STII) pump therapy on serum endotrophin (ETP) levels in patients with newly diagnosed type 2 diabetes, examine the relationship ...

Multidisciplinary and specialized care before, during, and after pregnancy is crucial in improving maternal and neonatal outcomes among patients with preexisting diabetes, according to a joint ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...